Biomarkers in renal-cell carcinoma: building on clinical paradigms
- PMID: 30416074
- DOI: 10.1016/S1470-2045(18)30674-0
Biomarkers in renal-cell carcinoma: building on clinical paradigms
Comment on
-
Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.Lancet Oncol. 2018 Dec;19(12):1688-1698. doi: 10.1016/S1470-2045(18)30648-X. Epub 2018 Nov 8. Lancet Oncol. 2018. PMID: 30416077 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical